MyAverix Finance
CO · Healthcare
Genmab A/S (GMAB)
Biotechnology
Genmab A/S (GMAB) is listed on CO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GMAB
P/E ratio
18.00
Genmab A/S (GMAB) — FAQ
What is GMAB's P/E ratio?
The price-to-earnings (P/E) ratio for Genmab A/S (GMAB) is 18.00 (data as of 2026-03-22).
Does Genmab A/S pay a dividend?
Dividend yield is not available in the current snapshot for Genmab A/S (GMAB). Check the MyAverix Finance app for the latest dividend data.
What sector is Genmab A/S in?
Genmab A/S (GMAB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GMAB listed on?
GMAB is listed on CO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.